December 18, 2017 RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today it is accelerating the development of new products based on its CellRaft™ Technology and expanding their availability in the marketplace. The CellRaft Technology, which allows researchers to easily... Read more
Luna DNA is the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community. SAN DIEGO, Dec. 18, 2017 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included... Read more
CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Dec. 8, 2017 — Neogen Corporation (NASDAQ: NEOG) today announced that its Board of Directors has approved a four-for-three stock split. With the split, shareholders of record on Dec. 18, 2017, will receive one additional share of stock for each three shares held. The stock split... Read more
Agreement includes payment of $27.5 million to Oxford, royalty-free license to QIAGEN and dismissal of all pending litigation Germantown, Maryland, and Hilden, Germany, December 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) and Oxford Immunotec Ltd. (NASDAQ: OXFD) announced today that they have reached a settlement in the lawsuit in the U.S. District... Read more
JENA/Germany, 2017-12-12. Today ZEISS announces ZEISS ZEN Intellesis, a new machine learning capability that enables researchers to perform advanced analysis of their imaging samples across multiple microscopy methods. The first algorithmic solution introduced by the ZEISS ZEN Intellesis platform makes integrated, easy to use, powerful segmentation for 2D and 3D datasets available to the routine... Read more
New members of the Executive Board of the ZEISS Group Effective 1 January 2018, Dr. Karl Lamprecht for the Semiconductor Manufacturing Technology segment and Dr. Jochen Peter for the Research & Quality Technology segment have been appointed to the Executive Board of the ZEISS Group Thomas Spitzenpfeil, Member of the Executive Board, to pursue new... Read more
Germantown, Maryland, and Hilden, Germany, December 08, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it is transferring the U.S. listing of its global shares to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. The transfer to the NYSE is expected to be effective on or about January... Read more
The real-time monitoring and prediction system, SIMCA®-online, constantly monitors processes to provide a continuous snapshot of the users’ operations. SIMCA® and SIMCA®-online software updates in the UmetricsTM Suite help manufacturing industries make better business decisions and optimize process control Goettingen, Germany / Malmö, Sweden – December 07, 2017: Sartorius Stedim Biotech (SSB), a leading international... Read more
12.06.17 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced it has been awarded a 10-year fielded contract through the United States Department of Defense’s (DOD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP) omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. 908 Devices is recognized for its patented and award-winning high-pressure mass spectrometry™ (HPMS) technology, which... Read more
Shimadzu announces the release of its C2MAP™-2000 automated pretreatment module for cell culture media analysis. This product is for pretreating culture media samples by adding reagents, such as a deproteinizing agent or internal standard substance, filtering precipitated proteins, and diluting samples. The C2MAP system combines the C2MAP-2000 module with a Shimadzu ultra-fast liquid chromatograph mass... Read more